Paper34767243
MiR-106b-5p Promotes Malignant Behaviors of Cervical Squamous Cell Carcinoma Cells by Targeting TIMP2.
Sun H and 1 other. Reprod Sci, 2022. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. MiR-106b-5p Promotes Malignant Behaviors of Cervical Squamous Cell Carcinoma Cells by Targeting TIMP2. Papers, record 34767243. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34767243
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- MiR-106b-5p Promotes Malignant Behaviors of Cervical Squamous Cell Carcinoma Cells by Targeting TIMP2.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Squamous Cell | Major topic |
| MicroRNAs | Major topic |
| Tissue Inhibitor of Metalloproteinase-2 | Major topic |
| Uterine Cervical Neoplasms | Major topic |
| Apoptosis | |
| Cell Line | |
| Cell Proliferation | |
| Female | |
| Gene Expression Regulation, Neoplastic | |
| HeLa Cells | |
| Humans |
Source PubMed
References40
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24913332 | Down-regulation of the expression of CCAAT/enhancer binding protein α gene in cervical squamous cell carcinoma. | BMC Cancer | 2014 | https://conductscience.org/library/papers/24913332 | PubMed |
| 2 | 24659184 | Oncostatin M receptor is a novel therapeutic target in cervical squamous cell carcinoma. | J Pathol | 2014 | https://conductscience.org/library/papers/24659184 | PubMed |
| 3 | 25798268 | Patient age, tumor appearance and tumor size are risk factors for early recurrence of cervical cancer. | Mol Clin Oncol | 2015 | https://conductscience.org/library/papers/25798268 | PubMed |
| 4 | 17991681 | miRBase: tools for microRNA genomics. | Nucleic Acids Res | 2008 | https://conductscience.org/library/papers/17991681 | PubMed |
| 5 | 29697201 | Mir-1307 regulates cisplatin resistance by targeting Mdm4 in breast cancer expressing wild type P53. | Thorac Cancer | 2018 | https://conductscience.org/library/papers/29697201 | PubMed |
| 6 | 29471827 | Nuclear functions of mammalian MicroRNAs in gene regulation, immunity and cancer. | Mol Cancer | 2018 | https://conductscience.org/library/papers/29471827 | PubMed |
| 7 | 30895717 | miR-146a-5p: Expression, regulation, and functions in cancer. | Wiley Interdiscip Rev RNA | 2019 | https://conductscience.org/library/papers/30895717 | PubMed |
| 8 | 29333098 | MiR-22-3p Regulates Cell Proliferation and Inhibits Cell Apoptosis through Targeting the eIF4EBP3 Gene in Human Cervical Squamous Carcinoma Cells. | Int J Med Sci | 2018 | https://conductscience.org/library/papers/29333098 | PubMed |
| 9 | 28802022 | MicroRNA-492 overexpression involves in cell proliferation, migration, and radiotherapy response of cervical squamous cell carcinomas. | Mol Carcinog | 2018 | https://conductscience.org/library/papers/28802022 | PubMed |
| 10 | 29552108 | miR-106b promotes cell invasion and metastasis via PTEN mediated EMT in ESCC. | Oncol Lett | 2018 | https://conductscience.org/library/papers/29552108 | PubMed |
| 11 | 28432562 | Increased expression of the microRNA 106b~25 cluster and its host gene MCM7 in corticotroph pituitary adenomas is associated with tumor invasion and Crooke's cell morphology. | Pituitary | 2017 | https://conductscience.org/library/papers/28432562 | PubMed |
| 12 | 30013364 | miR-106b-5p inhibits the invasion and metastasis of colorectal cancer by targeting CTSA. | Onco Targets Ther | 2018 | https://conductscience.org/library/papers/30013364 | PubMed |
| 13 | 29197876 | MiR-106b-5p Promotes Proliferation and Inhibits Apoptosis by Regulating BTG3 in Non-Small Cell Lung Cancer. | Cell Physiol Biochem | 2017 | https://conductscience.org/library/papers/29197876 | PubMed |
| 14 | 31503422 | miR-106b-5p promotes aggressive progression of hepatocellular carcinoma via targeting RUNX3. | Cancer Med | 2019 | https://conductscience.org/library/papers/31503422 | PubMed |
| 15 | 27470177 | Global burden of cancers attributable to infections in 2012: a synthetic analysis. | Lancet Glob Health | 2016 | https://conductscience.org/library/papers/27470177 | PubMed |
| 16 | 31416463 | The role of squamous cell carcinoma antigen (SCC Ag) in outcome prediction after concurrent chemoradiotherapy and treatment decisions for patients with cervical cancer. | Radiat Oncol | 2019 | https://conductscience.org/library/papers/31416463 | PubMed |
| 17 | 28209991 | MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. | Nat Rev Drug Discov | 2017 | https://conductscience.org/library/papers/28209991 | PubMed |
| 18 | 25424347 | Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway. | Mol Cancer | 2014 | https://conductscience.org/library/papers/25424347 | PubMed |
| 19 | 25985117 | A systematic investigation based on microRNA-mediated gene regulatory network reveals that dysregulation of microRNA-19a/Cyclin D1 axis confers an oncogenic potential and a worse prognosis in human hepatocellular carcinoma. | RNA Biol | 2015 | https://conductscience.org/library/papers/25985117 | PubMed |
| 20 | 28423523 | miR-106b-5p promotes renal cell carcinoma aggressiveness and stem-cell-like phenotype by activating Wnt/β-catenin signalling. | Oncotarget | 2017 | https://conductscience.org/library/papers/28423523 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41318838 | MiR-106b-5p promotes gastric cancer progression by directly targeting the tumor suppressor RBL2. | Sci Rep | 2025 | https://conductscience.org/library/papers/41318838 | PubMed |
| 40442905 | AAAGUGC Seed-Containing miRNAs: Master Regulators of Cancer Pathways and Therapeutic Resistance. | Microrna | 2025 | https://conductscience.org/library/papers/40442905 | PubMed |
| 40413660 | The role and diagnostic value of deregulated miRNAs in cervical cancer. | Discov Oncol | 2025 | https://conductscience.org/library/papers/40413660 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TIMP2 | 7077 | PubTator's text mining | https://conductscience.org/library/genes/7077 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34767243
GET https://conductscience.org/api/papers/v1/34767243/references?page=2